481P A phase I first-in-human study of XL092 in patients (pts) with locally advanced or metastatic solid tumors: Results from dose-escalation of XL092 alone and in combination with atezolizumab
- Resource Type
- Abstract
- Source
- In
Annals of Oncology September 2022 33 Supplement 7:S760-S760 - Subject
- Language
- ISSN
- 0923-7534